Browse drugs

…4 private payers spent more than $16 million and $14 million on esomeprazole and escitalopram, respectively, compared to their less expensiv…

…some technical deployment challenges. The fibrin-heparin coated Derivo 2heal showed encouraging early safety data, though current evidence i…

…s (338.7 vs 412.8 pmol/L, p<0.001) were significantly lower, in metformin users. Multiple regression analysis including variables that po…

…5% CI 1.03, 1.22) were more likely to report willingness to use doxycycline prophylaxis. Concerns about daily medication (aOR 0.43; 95% CI …

…se to methotrexate, he was subsequently shifted to intravitreal rituximab injections. He received monthly intravitreal injections of ritu…

… Everolimus and its association with gastrointestinal bleeding. Everolimus was withheld. As he had tolerated the mTOR inhibitor for 10 yea…

…, with a focus on paediatric use and health system integration. SLDPQ scale-up should be prioritised within malaria elimination strat…

…iency and the requirement for Dual Antiplatelet Therapy (DAPT), aspirin was considered as a treatment option after thorough consultatio…

…ACE and 6.7, 6.4, and 9.3 for first AKI respectively. Receiving SGLT2is at discharge significantly reduced the risk of MACE (hazard rat…

…duction of 52% ±12 (95% CI) was found in those with statins and Inclisiran. For those intolerant of statins, use of Inclisiran led to a me…

… enzymatic and non-enzymatic antioxidants in the heart of rats. Ambroxol significantly alleviated CP-induced cardiotoxicity, as evidence…

…red, followed by either 10 mg/kg of bevacizumab or 2.4 mg/kg of carboplatin. Serial MRI was obtained post-treatment to assess tumor respons…